EuroHealth | 16 January 2024

Healthcare policy decisions in the European Union are largely supply-driven. To move towards needs-driven healthcare innovation and policy, patient and societal needs should be defined upfront and subsequently guide decisions of researchers, research funders, regulators and health technology assessment bodies. This article argues that the EU pharmaceutical regulation, EU HTA regulation and EU research funding programmes can stimulate this effort.